MMP13 and arthritic joint disease: In the ERN1 cKO ACLT mouse model, more severe loss of proteoglycan in safranin O staining, a significantly higher arthritis score, elevated expression of MMP13 and ADAMTS5, and reduced expression of aggrecan and Col2 were observed (Fig. 2).